Simplex Trading’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-137
| Closed | -$1K | – | 3463 |
|
|
2025
Q1 | $1K | Buy |
+137
| New | +$1K | ﹤0.01% | 2192 |
|
|
2024
Q4 | – | Sell |
-2,914
| Closed | -$137K | – | 3451 |
|
|
2024
Q3 | $137K | Buy |
2,914
+1,368
| +88% | +$64.3K | ﹤0.01% | 1000 |
|
|
2024
Q2 | $77K | Buy |
1,546
+1,224
| +380% | +$61K | ﹤0.01% | 1225 |
|
|
2024
Q1 | $36K | Buy |
322
+89
| +38% | +$9.95K | ﹤0.01% | 1501 |
|
|
2023
Q4 | $13K | Sell |
233
-218
| -48% | -$12.2K | ﹤0.01% | 1771 |
|
|
2023
Q3 | $14K | Sell |
451
-2,183
| -83% | -$67.8K | ﹤0.01% | 1567 |
|
|
2023
Q2 | $216K | Buy |
2,634
+812
| +45% | +$66.6K | ﹤0.01% | 801 |
|
|
2023
Q1 | $187K | Buy |
1,822
+1,698
| +1,369% | +$174K | ﹤0.01% | 813 |
|
|
2022
Q4 | $18K | Buy |
124
+74
| +148% | +$10.7K | ﹤0.01% | 1641 |
|
|
2022
Q3 | $8K | Sell |
50
-537
| -91% | -$85.9K | ﹤0.01% | 2068 |
|
|
2022
Q2 | $67K | Sell |
587
-100
| -15% | -$11.4K | ﹤0.01% | 1291 |
|
|
2022
Q1 | $68K | Buy |
+687
| New | +$68K | ﹤0.01% | 1581 |
|
|
2021
Q4 | – | Sell |
-7
| Closed | -$2K | – | 3785 |
|
|
2021
Q3 | $2K | Sell |
7
-4
| -36% | -$1.14K | ﹤0.01% | 2639 |
|
|
2021
Q2 | $3K | Sell |
11
-30
| -73% | -$8.18K | ﹤0.01% | 2642 |
|
|
2021
Q1 | $16K | Sell |
41
-45
| -52% | -$17.6K | ﹤0.01% | 2051 |
|
|
2020
Q4 | $57K | Buy |
+86
| New | +$57K | ﹤0.01% | 1493 |
|
|
2020
Q3 | – | Sell |
-71
| Closed | -$41K | – | 2796 |
|
|
2020
Q2 | $41K | Buy |
+71
| New | +$41K | ﹤0.01% | 1288 |
|